Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

(2021) Sia Viborg Lindskrog et al.   Nature Communications

Identification of Differential Tumor Subtypes of T1 Bladder Cancer

(2020) A. Gordon Robertson et al.   EUROPEAN UROLOGY

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer

(2020) Andrea Necchi et al.   EUROPEAN UROLOGY

Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer

(2020) Michaela Bowden et al.   Scientific Reports

Molecular Characterization of Neuroendocrine-like Bladder Cancer

(2019) José Batista da Costa et al.   CLINICAL CANCER RESEARCH

Higher Expression of Linc00152 Promotes Bladder Cancer Proliferation and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway

(2019) Tang Xian-li et al.   MEDICAL SCIENCE MONITOR

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer

(2019) Aurélie Kamoun et al.   EUROPEAN UROLOGY

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†

(2019) J. Alfred Witjes et al.   EUROPEAN UROLOGY

Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer

(2019) Vera Genitsch et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Micropapillary urothelial carcinoma of urinary bladder displays immunophenotypic features of luminal and p53-like subtypes and is not a variant of adenocarcinoma

(2019) Yu Yang et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis

(2019) Joep J. de Jong et al.   Genome Medicine

UCA1 long non-coding RNA: An update on its roles in malignant behavior of cancers

(2019) Soudeh Ghafouri-Fard et al.   BIOMEDICINE & PHARMACOTHERAPY

Molecular and clinical heterogeneity within the luminal subtype

(2019) Joep J. de Jong et al.   Nature Reviews Urology

Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy

(2019) Petros Grivas et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype

(2018) Ulrike Zinnall et al.   HUMAN PATHOLOGY

Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes

(2018) Mohammad Abufaraj et al.   EUROPEAN UROLOGY

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

(2017) Roland Seiler et al.   EUROPEAN UROLOGY

Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification

(2017) Gottfrid Sjödahl et al.   JOURNAL OF PATHOLOGY

Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer

(2016) Charles Chuanhai Guo et al.   EUROPEAN UROLOGY

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

(2014) Woonyoung Choi et al.   CANCER CELL

TGF- -Induced Upregulation of malat1 Promotes Bladder Cancer Metastasis by Associating with suz12

(2014) Y. Fan et al.   CLINICAL CANCER RESEARCH

The hallmarks of cancer

(2012) Tony Gutschner et al.   RNA Biology

Human Cancer Long Non-Coding RNA Transcriptomes

(2011) Ewan A. Gibb et al.   PLoS One